Advocacy

Drug ARM supports:

• Volumetric taxation
• Advertising controls
• Ban on industry driven political donations
• Licensing controls including opening hour restrictions, reduced outlet density and promotion bans

Drug ARM supports

• Diversion options
• Further research into decriminalisation

Drug ARM does not support

• Legalisation
• Decriminalisation

Drug ARM supports

• An appropriate regulatory and legislative framework for electronic cigarette (nicotine and
  non-nicotine) use, sales, promotion and regulation

Drug ARM does not support

• The claim that e-cigarettes are a safe and approved nicotine replacement therapy

Drug ARM E-Cigarettes and Vaping Policy Position

Drug ARM supports

• Oral administration of medical cannabis
• Evaluation and review of medical cannabis
• Ongoing clinical trials

Drug ARM does not support

• Provision of heroin to users

Drug ARM supports

• Legislative framework for regulating alcohol advertising and promotion
• Restricting alcohol advertising and promotion
• Restricting sponsorship of events by alcohol companies
• Research on impact and effect of alcohol marketing on young people

Drug ARM supports the introduction of minimum unit pricing.

Drug ARM supports needle and syringe supply programs as a viable public health and treatment intervention.

Drug ARM supports the methadone program with maintenance and reduction options for clients and a point of closure to reduce long term exposure to methadone harms.

Drug ARM supports trials of pill testing in Australia.

Drug ARM supports the following in prison settings:

• Naltrexone treatment
• Opiate pharmacotherapy
• Condoms to reduce spread of blood borne viruses